Ovidrel is a Subcutaneous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Emd Serono, Inc.. The primary component is Choriogonadotropin Alfa.
| Product ID | 44087-1150_2effd6d1-bdd0-44b1-a07c-244923067d94 |
| NDC | 44087-1150 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Ovidrel |
| Generic Name | Choriogonadotropin Alfa |
| Dosage Form | Injection, Solution |
| Route of Administration | SUBCUTANEOUS |
| Marketing Start Date | 2003-10-06 |
| Marketing Category | NDA / NDA |
| Application Number | NDA021149 |
| Labeler Name | EMD Serono, Inc. |
| Substance Name | CHORIOGONADOTROPIN ALFA |
| Active Ingredient Strength | 250 ug/.5mL |
| Pharm Classes | Gonadotropin [EPC],Gonadotropins [CS] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2020-12-31 |
| Marketing Start Date | 2003-10-06 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | NDA |
| Application Number | NDA021149 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | ML |
| Marketing Start Date | 2003-10-06 |
| Ingredient | Strength |
|---|---|
| CHORIOGONADOTROPIN ALFA | 250 ug/.5mL |
| SPL SET ID: | a683e58a-63ea-44b8-a326-1a99a537bcf2 |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 44087-1150 | Ovidrel | choriogonadotropin alfa |
| 0052-0315 | Pregnyl | CHORIOGONADOTROPIN ALFA |
| 50090-5923 | Pregnyl | CHORIOGONADOTROPIN ALFA |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() OVIDREL 77524655 3604207 Live/Registered |
MERCK KGAA 2008-07-17 |
![]() OVIDREL 76978250 3185427 Live/Registered |
MERCK KGAA 2004-12-17 |
![]() OVIDREL 76624777 not registered Dead/Abandoned |
Ares Trading S.A. 2004-12-17 |
![]() OVIDREL 74380635 1972079 Live/Registered |
MERCK KGAA 1993-04-16 |
![]() OVIDREL 73586039 1448088 Dead/Cancelled |
ARES SERONO NV, AMSTERDAM, SUCCURSALE DE GENEVE 1986-03-04 |